ANTIEPILEPTIC DRUG PRESCRIBING PATTERNS AND CLINICAL OUTCOMES IN PEDIATRIC SEIZURE DISORDERS: A CROSS-SECTIONAL STUDY FROM A TERTIARY CARE HOSPITAL IN KASHMIR

Main Article Content

Rehana Tabassum
Asra Laraib
Shafat Ahmad Tak

Keywords

antiepileptic drugs, drug utilization study, pediatric epilepsy, levetiracetam, Kashmir, prescribing pattern

Abstract

Background: Anticonvulsant prescribing in children must balance seizure control against the vulnerabilities of a developing brain, yet drug utilization data from paediatric epilepsy populations in the Kashmir valley remain scarce.
Objectives: To describe the demographic, clinical, and etiological profile of children admitted with seizure disorders; to characterize antiepileptic drug (AED) prescribing patterns; and to determine short-term clinical outcomes at discharge and their association with therapy pattern and seizure category.
Methods: This cross-sectional, observational study enrolled 200 children (<18 years) admitted with seizure disorders to a tertiary paediatric referral centre in Srinagar, following Institutional Ethics Committee approval (Ref. IRBGMC-SGR/Pharma/533). Structured, pretested proformas captured demographic, clinical, aetiological, investigational, and prescribing variables. Data were analysed in SPSS v26.0; categorical comparisons used the chi-square test, with p<0.05 considered significant.
Results: Infants (≤1 year) formed the largest age group (36.0%), with a male predominance (59.0%, M:F 1.44:1) and a majority from lower-middle socioeconomic strata (70.0%). Epilepsy with acute symptomatic seizures accounted for 69.0% of admissions; structural brain abnormalities (31.5%) and idiopathic causes (31.0%) were the leading aetiologies. Levetiracetam was the most frequently prescribed AED (62.0%), followed by sodium valproate (49.0%); monotherapy was used in 56.0% of patients. A favourable outcome at discharge (seizure controlled or improved) was achieved in 89.0% of patients, and was more frequent with monotherapy than polytherapy (92.9% vs 84.1%) and in acute symptomatic seizures than epileptic encephalopathy (91.3% vs 80.0%).
Conclusion: Levetiracetam-predominant, largely monotherapy-based prescribing in this Kashmiri paediatric cohort was associated with favourable short-term seizure outcomes, while epileptic encephalopathy and polytherapy subgroups showed higher rates of partial or poor discharge outcomes reflecting greater underlying disease severity. Underutilisation of EEG (54.0%) and neuroimaging (53.0%) represents an actionable diagnostic gap.


 

Abstract 0 | PDF Downloads 0

References

1.World Health Organization. Introduction to Drug Utilization Research. Geneva: WHO; 2003.
2.Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020;54(2):185–191.
3.Camfield P, Camfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 2015;17(2):117–123.
4.Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus. Epilepsia. 2015;56(10):1515–1523.
5.Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy. Epilepsia. 2017;58(4):522–530.
6.Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults. Epilepsy Curr. 2016;16(1):48–61.
7.Nardou R, Ferrari DC, Ben-Ari Y. Mechanisms and effects of seizures in the immature brain. Semin Fetal Neonatal Med. 2011;18(4):175–184.
8.Zargar AH, Masoodi SR, Laway BA, et al. Epilepsy in Kashmir: epidemiological and clinical profile. J Indian Med Assoc. 2017;108(4):245–249.
9.Raina SK, Razdan S, Pandita KK, et al. Prevalence of epilepsy in children (3–10 years) in RS Pura of Jammu and Kashmir state. J Pediatr Neurosci. 2019;7(3):159–161.
10.Ahmad S, Bhat NA, Jan GM. Prevalence of vitamin D deficiency and its association with seizures in children of Kashmir valley. J Indian Soc Pedod Prev Dent. 2016;34(1):87–90.
11.Khoshdel Z, Tomas S, Jafari M. Drug utilization study of antiepileptic drugs in the pediatric department, tertiary care hospital, Bangalore, India. J Family Med Prim Care. 2022;11(6):2393–2398.
12.Kamlekar SK, Nandile K, Meshram R. Cross-sectional observational study of anticonvulsant prescription patterns in children attending a neurology outpatient department. J Pharm Bioallied Sci. 2023;15(2):89–95.
13.Patel MK, Patel HR, Patel PP, Dikshit RK. Drug utilization study of antiepileptic drugs in pediatric patients at a tertiary care teaching hospital. Natl J Physiol Pharm Pharmacol. 2018;8(7):1037–1041.
14.Mehndiratta MM, Paul P, Singh M, et al. Prescribing patterns, seizure outcomes and adverse effects of antiepileptic drugs across seven neurology centres in India. Epilepsy Behav. 2022;131(Pt A):108697.
15.Albsoul-Younes A, Gharaibeh L, Murtaja AA, et al. Patterns of antiepileptic drug use in epileptic pediatric patients in Jordan. Neurosciences (Riyadh). 2016;21(3):264–267.
16.Egunsola O, Choonara I, Sammons HM. Anti-epileptic drug utilisation in paediatrics: a systematic review. BMJ Paediatr Open. 2017;1(1):e000088.
17.Liu X, Carney PR, Bussing R, et al. Trends in antiepileptic drug use in children and adolescents with epilepsy. Pediatr Neurol. 2017;74:32–40.
18.Peymani P, Hosseini SA, Saidpour A, Ghahramani F. Global trends in antiseizure medication prescribing: a pharmacoepidemiological review (2010–2023). Pharmacoepidemiol Drug Saf. 2024;33(3):e5762.
19.Sahu R, Agarwal M, Mishra S. Prescribing patterns and treatment outcomes in newly diagnosed childhood epilepsy: a prospective cohort study. Cureus. 2022;14(9):e29361.
20.Alsabri M, Shaikh MF, Garcia-Cairasco N, Bhatt DL. Levetiracetam for convulsive status epilepticus in pediatric patients: systematic review and pooled analysis. Seizure. 2025;115:12–21.
21.Suthar M, Chauhan A, Trivedi P, Patel S. Concomitant medication use and polypharmacy burden in pediatric epilepsy patients at a tertiary care hospital. J Child Neurol. 2024;39(1–2):27–35.
22.Endayen D, Tegene B, Haile K. Antiepileptic drug utilization patterns and treatment outcomes in pediatric epilepsy at a tertiary referral hospital in Ethiopia. BMC Pediatr. 2022;23(1):445.